Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, Xiamen, Fujian, China
Eur J Hosp Pharm. 2024 Feb 22;31(2):101-106. doi: 10.1136/ejhpharm-2021-003170.
Prescription errors can cause serious adverse drug events. Clinical decision support systems prevent prescription errors; however, real-time clinical rules in obstetrics, gynaecology, and paediatric outpatients remain unexplored. We evaluated the effects of localised, real-time clinical rules on alert rates and acceptance rates compared with manual prescription review.
We developed real-time clinical rules that incorporate information systems to obtain characteristic information and laboratory values. We conducted a retrospective cohort study to compare the alert and recommendation acceptance rates of all prescription error types before and after clinical rule implementation in obstetrics, gynaecology, and paediatrics. Clinical rules, prescription error types, and alerts were determined by a prescribing review committee comprising physicians, pharmacists, nurses, and administrators. The difference in alert and acceptance rates between the groups was analysed using relative risk.
The number of alerts increased after clinical rules implementation; the number of on-duty pharmacists for review decreased from 10 to 2. Compared with those with manual review, the alert rates for paediatrics and obstetrics and gynaecology increased with the clinical rules by 3.97- and 11.26-fold, respectively, and the alert rates for drug-drug interactions (DDIs) and combined medication errors in obstetrics and gynaecology increased with the clinical rules by 26.10- and 26.54-fold, respectively. In paediatrics, the alert rate for all prescription error types was higher with the clinical rules review than with the manual review; the alert rates for DDI, dosage, and combination medication errors were significantly different between the clinical rules and the manual review. However, there was no difference in the recommendation acceptance rate between the manual review and the clinical rules.
Clinical rules can identify prescription errors that manual review cannot detect and ensure real-time review efficiency in high-volume outpatient prescription settings. The high acceptance rate and modification of prescriptions may be relevant to highly customised and localised clinical rules.
处方错误可能导致严重的药物不良事件。临床决策支持系统可预防处方错误;然而,妇产科和儿科门诊的实时临床规则仍未得到探索。我们评估了局部实时临床规则对警报率和接受率的影响,与手动处方审查相比。
我们开发了实时临床规则,这些规则结合了信息系统来获取特征信息和实验室值。我们进行了一项回顾性队列研究,比较了妇产科和儿科实施临床规则前后所有处方错误类型的警报和建议接受率。临床规则、处方错误类型和警报由一个由医生、药剂师、护士和管理人员组成的处方审查委员会确定。使用相对风险分析比较两组之间的警报和接受率差异。
实施临床规则后,警报数量增加;审查值班药剂师人数从 10 人减少到 2 人。与手动审查相比,儿科和妇产科的警报率分别通过临床规则增加了 3.97 倍和 11.26 倍,妇产科的药物-药物相互作用(DDI)和联合用药错误的警报率分别通过临床规则增加了 26.10 倍和 26.54 倍。在儿科,所有处方错误类型的警报率均高于临床规则审查;DDI、剂量和联合用药错误的警报率在临床规则和手动审查之间存在显著差异。然而,手动审查和临床规则之间的建议接受率没有差异。
临床规则可以识别手动审查无法检测到的处方错误,并确保在高容量门诊处方环境中实现实时审查效率。高接受率和处方修改可能与高度定制化和本地化的临床规则有关。